Startups
PhageTech, Inc. is a California-based, developmental stage company applying an innovative approach for detecting disease markers in body fluids including urine and blood. Compared to current antibody-based assays, PhageTech's approach could offer improved sensitivity and performance. Furthermore, our technology has the potential to be more stable and less expensive than current testing methods.
The PhageTech, Inc. technology platform promises to deliver rapid and accurate diagnostic screening for testing at a fraction of current costs. The core technology utilized in PhageTech devices was developed by two research groups at the University of California, Irvine, and was the subject of nine pending and issued patents. Recently, protein sensing with the PhageTech platform has been demonstrated with PSMA (Prostate-specific membrane antigen) and HSA (Human Serum Albumin). These targets could impact the diagnosis of prostate cancer and kidney disease, respectively. Our technology has the potential to touch every field of medicine and profoundly impact the administration of health care around the world.
The PhageTech, Inc. technology platform promises to deliver rapid and accurate diagnostic screening for testing at a fraction of current costs. The core technology utilized in PhageTech devices was developed by two research groups at the University of California, Irvine, and was the subject of nine pending and issued patents. Recently, protein sensing with the PhageTech platform has been demonstrated with PSMA (Prostate-specific membrane antigen) and HSA (Human Serum Albumin). These targets could impact the diagnosis of prostate cancer and kidney disease, respectively. Our technology has the potential to touch every field of medicine and profoundly impact the administration of health care around the world.
Overview
Location
United States, California, Irvine
Employees
11-50
Total raised
$2.4M
Founded date
2014
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 4
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Sep 28, 2015 | PhageTech Raises $2.4M in Series A Funding | PhageTech, Inc., an Irvine, CA-based development stage company with a platform that employs a bacteriophage substrate for detecting analytes in urine, blood and most any other body fluid, raised $2.4m in Series A funding. The round was co-l... |
| Sep 28, 2015 | PhageTech Finds $2.4M For Biosensors For Disease Detection | Irvine-based PhageTech, a developer of disease detection sensors, said late Monday morning that it has raised $2.4M in a funding round. The Series A funding came from Mark IV Capital and Black River Investments. According to PhageTech it is... |
| PhageTech raises $2.4 million in Series A for early disease detection – headed for FDA approval | PhageTech, Inc. announced today that it has raised $2.4 million in Series A funding that will be used to complete development of its Biosensors – which are designed to enable early detection of cancers and other diseases. The technology wou... |
Reviews 0
FAQ about PhageTech, Inc.
When was PhageTech, Inc. founded?
PhageTech, Inc. was founded in 2014.
How much funding has PhageTech, Inc. raised?
PhageTech, Inc. has raised $2.4M in total across 1 funding round.
What has the press written about PhageTech, Inc.?
Parsers VC has collected 4 articles mentioning PhageTech, Inc., among them “PhageTech Raises $2.4M in Series A Funding” (Sep 28, 2015) and “PhageTech Finds $2.4M For Biosensors For Disease Detection” (Sep 28, 2015).
Is PhageTech, Inc. still active?
Yes, PhageTech, Inc. is active; its latest activity on Parsers VC dates from Sep 28, 2015.